About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Clinical Trial on Cancer Drug Durvalumab Halted Temporarily

by Julia Samuel on October 28, 2016 at 6:41 PM
Font : A-A+

Clinical Trial on Cancer Drug Durvalumab Halted Temporarily

Clinical trails for the cancer drug durvalumab is halted by regulators, announced Drugmaker AstraZeneca.

AstraZeneca said that the US Food and Drug Administration's partial hold on new patients with that kind of condition came in response to concerns over bleeding. The company said it had submitted its analysis of reported adverse events to regulators for review in order to address the issues and restart patient enrolment as soon as possible.

Advertisement


AstraZeneca has pinned hopes on durvalumab as a potential breakthrough treatment for several forms of cancer. The immunotherapy is designed to use the patient's own defence system to attack tumours, overwhelming their immune-evading systems, and is being studied as a potential treatment for various forms of the disease, including bladder, gastric, pancreatic, head and neck, and blood cancers.

Shares in the UK-based drugmaker have fallen more than 9.8 percent from a year earlier in the US, where it recently announced a $1.1bn cost-cutting plan to accelerate its shift away from mass-market primary care products and towards a new generation of specialised cancer medications.
Advertisement

The increased focus on R&D comes as it attempts to re calibrate following the recent losses of patent protection for mass-market blockbusters such as cholesterol treatment Crestor and its Nexium heartburn pill. AstraZeneca has described durvalumab as the cornerstone of its bid to develop drugs that can harness the body's immune system to fight cancer.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Clinical Trials Cancer and Homeopathy Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Drugs Banned in India 

Most Popular on Medindia

Calculate Ideal Weight for Infants Drug - Food Interactions Blood - Sugar Chart Accident and Trauma Care Loram (2 mg) (Lorazepam) Iron Intake Calculator Pregnancy Confirmation Calculator The Essence of Yoga Drug Interaction Checker Turmeric Powder - Health Benefits, Uses & Side Effects
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Clinical Trial on Cancer Drug Durvalumab Halted Temporarily Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests